EUCTR2012-002053-29-SE进行中（未招募）不适用
PET/CT-biopsi studyA PET/CT biopsy sub study in patients who have given informed consent to participate in a randomized, dubbel blind, placebo controlled phase III trial with Capecitabine +/- Sorafenib in the treatment of locally advanced or metastatic HER2-negative breast cancer.
Karolinska Institutet and University Hospital0 个研究点开始时间: 2012年7月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Signed Informed Consent for participation in the trial 12444 with EudraCT number 2012-018501-10.
- •Signed Informed Consent for this trial.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Not defined.
研究者
相似试验
已完成
1 期
A PET (positron emission tomography) clinical research study using prostate specific membrane antigen (PSMA) targeted tracer, 89Zr-Df-IAB2MProstate cancer / Urothelial carcinoma / Renal cell carcinoma / Testicular cancerJPRN-UMIN000015356niversity of Tsukuba15
招募中
不适用
A clinical trial to examine age-and-sex-related changes of AMPA receptor density in healthy volunteers.Healthy volunteersJPRN-jRCTs031200083Abe Hiroki100
已完成
不适用
[F-18]FDG and [C-11]Acetate PET/CT study for refractory diseasesJPRN-UMIN000023101Tokyo Medical and Dental University40
已完成
不适用
A pilot study of clinical usefulness of PET-CT and PET-MRI in cancer patients treated with medical tharapyCancerJPRN-UMIN000017136Department of Surgery, Fukushima Medical University100
已完成
1 期
A PET (positron emission tomography) study using 89Zr-Df-IAB2M for gliomaGliomaJPRN-UMIN000018639niversity of Tsukuba10